Avalere Announces Departure of President Elizabeth Carpenter, Appointment of Interim President Sarah Alwardt

  • This page as PDF


Elizabeth Carpenter will step down as Avalere President. Sarah Alwardt will lead Avalere on an interim basis.

Avalere announces the departure of Elizabeth Carpenter, president of Avalere and head of Fishawack Health’s Policy, Access, Value, and Evidence (PAVE) capability in the United States. In her 10 years at Avalere, Elizabeth deftly led the firm’s consulting, sales, and operational teams through a period of substantial growth for the firm and significant changes in the healthcare landscape. She will join PhRMA as executive vice president of Policy and Research.

Sarah Alwardt, PhD, Senior Vice President, will serve as interim president of Avalere and head of PAVE US as the company launches an internal and external search.

Sarah currently leads Avalere’s Evidence & Strategy practice, where she identifies and convenes key players across the care continuum to transform healthcare and give patients a voice. Sarah has over 20 years of experience in leadership, strategy, and operations for biopharmaceutical industries, with expertise in real-world data and advanced analytics related to maximizing product value and performance.

As interim president, Sarah will work closely with the leadership teams of Avalere and its broader organization, Fishawack Health, to ensure that the firm continues to develop practical solutions for clients that are driven by robust data and deep healthcare expertise. For questions or inquiries, please contact media@avalere.com.

Webinar | Election 2024: What’s at Stake for Healthcare? 

On August 14 at 1:30 PM ET, Avalere experts and guests will discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders. 

Learn More

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top